no scripts enabled
Medikabazaar
Cart
Insight DOA Panel 6.1 - Pack of 10 Tests
Insight DOA Panel 6.1 - Pack of 10 Tests: Image 1
Insight DOA Panel 6.1 - Pack of 10 Tests: Image 2
Insight DOA Panel 6.1 - Pack of 10 Tests: Image 3
Insight DOA Panel 6.1 - Pack of 10 Tests: Image 4
Insight DOA Panel 6.1 - Pack of 10 Tests: Image 5
Insight DOA Panel 6.1 - Pack of 10 Tests: Image 6
Insight DOA Panel 6.1 - Pack of 10 Tests: Image 7
Insight DOA Panel 6.1 - Pack of 10 Tests: Image 8
Insight DOA Panel 6.1 - Pack of 10 Tests: Image 9

Your Advantages

Insight DOA Panel 6.1 - Pack of 10 Tests

₹990

Exclusive of 5% GST

Pack Size

Variant unavailable, Please select another variant

Brand Insight

What's in the Box

Membrane test assembly, Sample applicator, Desiccant pouch, Package insert

Description:
The Insight DOA Panel 6.1 is a comprehensive drug testing solution designed for rapid and accurate detection of multiple drugs of abuse in urine specimens. This panel test provides a reliable and convenient method for screening six commonly abused substances, ensuring high sensitivity and specificity. The pack includes 10 test panels, making it suitable for various clinical and workplace settings where efficient drug testing is essential.

Performance Characteristics:

  1. Sensitivity:

    • THC (Tetrahydrocannabinol): Detects THC at concentrations ≥ 50 ng/ml.
    • AMP (Amphetamine): Detects amphetamine at concentrations ≥ 1000 ng/ml.
    • BAR (Barbiturates): Detects barbiturates at concentrations ≥ 300 ng/ml.
    • BZO (Benzodiazepines): Detects benzodiazepines at concentrations ≥ 300 ng/ml.
    • COC (Cocaine): Detects cocaine at concentrations ≥ 300 ng/ml.
    • OPI (Morphine): Detects morphine at concentrations ≥ 300 ng/ml.
  2. Specificity:

    • The test demonstrates no cross-reactivity with non-drug related compounds at concentrations significantly higher than typical urine levels.
    • Extensive studies confirm that substances potentially present in urine, along with variations in sample pH and specific gravity, do not interfere with the test's accuracy.
    • The assay devices have been validated to ensure no cross-reactivity with a comprehensive list of non-drug substances, ensuring reliable and accurate results.

Key Features and Benefits:

  • Multi-Drug Detection: Efficiently screens for six major drugs of abuse in a single test, providing comprehensive results.
  • High Sensitivity: Detects drugs at low concentrations, ensuring reliable identification of drug use.
  • Specificity: High specificity reduces the likelihood of false positives, enhancing the accuracy of the test.
  • User-Friendly: Easy-to-use design allows for quick and straightforward administration and interpretation of results.
  • Reliable Performance: Consistent and accurate results make it an invaluable tool for drug screening in clinical and workplace environments.
  • Convenient Packaging: Pack of 10 tests ensures availability for multiple screenings, making it cost-effective and practical for frequent use.
Material / Reagent TypeMembrane test assembly with colloidal gold conjugated antibodies
Clinical / Analytical FunctionRapid, qualitative, immunochromatographic assay for simultaneous detection of six drugs of abuse in human urine
Regulatory ApprovalFor in vitro diagnostic and professional use
Storage Conditions4 - 30°C
twitterlinkedinfacebookinstagramyoutube
@Copyright Boston Ivy Healthcare Solutions Private Limited